Literature DB >> 19081073

The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development.

Ariadna Laguna1, Sergi Aranda, María José Barallobre, Rima Barhoum, Eduardo Fernández, Vassiliki Fotaki, Jean Maurice Delabar, Susana de la Luna, Pedro de la Villa, Maria L Arbonés.   

Abstract

The precise regulation of programmed cell death is critical for the normal development of the nervous system. We show here that DYRK1A (minibrain), a protein kinase essential for normal growth, is a negative regulator of the intrinsic apoptotic pathway in the developing retina. We provide evidence that changes in Dyrk1A gene dosage in the mouse strongly alter the cellularity of inner retina layers and result in severe functional alterations. We show that DYRK1A does not affect the proliferation or specification of retina progenitor cells, but rather regulates the number of cells that die by apoptosis. We demonstrate that DYRK1A phosphorylates caspase-9 on threonine residue 125, and that this phosphorylation event is crucial to protect retina cells from apoptotic cell death. Our data suggest a model in which dysregulation of the apoptotic response in differentiating neurons participates in the neuropathology of diseases that display DYRK1A gene-dosage imbalance effects, such as Down's syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19081073     DOI: 10.1016/j.devcel.2008.10.014

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  50 in total

Review 1.  The regulatory crosstalk between kinases and proteases in cancer.

Authors:  Carlos López-Otín; Tony Hunter
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

2.  Towards Gram-positive antivirulence drugs: new inhibitors of Streptococcus agalactiae Stk1.

Authors:  Mayalen Oxoby; François Moreau; Lionel Durant; Alexis Denis; Jean-Marie Genevard; Vanida Vongsouthi; Sonia Escaich; Vincent Gerusz
Journal:  Bioorg Med Chem Lett       Date:  2010-06-15       Impact factor: 2.823

3.  Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A).

Authors:  Tatyana Adayev; Jerzy Wegiel; Yu-Wen Hwang
Journal:  Arch Biochem Biophys       Date:  2010-12-24       Impact factor: 4.013

4.  The Down syndrome critical region regulates retinogeniculate refinement.

Authors:  Martina Blank; Peter G Fuerst; Beth Stevens; Navid Nouri; Lowry Kirkby; Deepti Warrier; Ben A Barres; Marla B Feller; Andrew D Huberman; Robert W Burgess; Craig C Garner
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

Review 5.  Cellular mechanisms controlling caspase activation and function.

Authors:  Amanda B Parrish; Christopher D Freel; Sally Kornbluth
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-06-01       Impact factor: 10.005

6.  Restraint of apoptosis during mitosis through interdomain phosphorylation of caspase-2.

Authors:  Joshua L Andersen; Carrie E Johnson; Christopher D Freel; Amanda B Parrish; Jennifer L Day; Marisa R Buchakjian; Leta K Nutt; J Will Thompson; M Arthur Moseley; Sally Kornbluth
Journal:  EMBO J       Date:  2009-09-03       Impact factor: 11.598

7.  p53 downregulates Down syndrome-associated DYRK1A through miR-1246.

Authors:  Yu Zhang; Jun-Ming Liao; Shelya X Zeng; Hua Lu
Journal:  EMBO Rep       Date:  2011-06-03       Impact factor: 8.807

8.  The phosphorylation status of T522 modulates tissue-specific functions of SIRT1 in energy metabolism in mice.

Authors:  Jing Lu; Qing Xu; Ming Ji; Xiumei Guo; Xiaojiang Xu; David C Fargo; Xiaoling Li
Journal:  EMBO Rep       Date:  2017-03-31       Impact factor: 8.807

9.  Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease.

Authors:  Ariadna Laguna; Nicoletta Schintu; André Nobre; Alexandra Alvarsson; Nikolaos Volakakis; Jesper Kjaer Jacobsen; Marta Gómez-Galán; Elena Sopova; Eliza Joodmardi; Takashi Yoshitake; Qiaolin Deng; Jan Kehr; Johan Ericson; Per Svenningsson; Oleg Shupliakov; Thomas Perlmann
Journal:  Nat Neurosci       Date:  2015-04-27       Impact factor: 24.884

10.  DYRK1A, a novel determinant of the methionine-homocysteine cycle in different mouse models overexpressing this Down-syndrome-associated kinase.

Authors:  Christophe Noll; Chris Planque; Clémentine Ripoll; Fayçal Guedj; Anna Diez; Véronique Ducros; Nicole Belin; Arnaud Duchon; Jean-Louis Paul; Anne Badel; Bénédicte de Freminville; Yann Grattau; Henri Bléhaut; Yann Herault; Nathalie Janel; Jean-Maurice Delabar
Journal:  PLoS One       Date:  2009-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.